StonvexLoading…
StonvexStonvexStonvexCore line items from SO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $7.48B | $8.04B | $28.94B | $22.14B | $14.33B |
Operating Income | Not available | $2.02B | $7.29B | $6.37B | $3.77B |
Net Income | Not available | $1.36B | $4.34B | $3.92B | $2.21B |
EPS (Diluted) | $1.02 | $1.20 | $3.92 | $3.54 | $2.00 |
Total Assets | Not available | $157.03B | $155.72B | $153.25B | $148.85B |
Total Liabilities | Not available | $117.12B | $116.85B | $114.97B | $111.51B |
Cash & Equivalents | Not available | $981.00M | $1.64B | $3.34B | $1.26B |
Free Cash Flow OCF − CapEx | Not available | $-1.72B | $-2.94B | $-1.25B | $-1.81B |
Shares Outstanding | Not available | 1.13B | 1.11B | 1.11B | 1.11B |